KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Intangibles (2018 - 2025)

Vir Biotechnology (VIR) has disclosed Intangibles for 8 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • Quarterly Intangibles fell 3.33% to $7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.8 million through Dec 2025, down 3.33% year-over-year, with the annual reading at $7.8 million for FY2025, 3.33% down from the prior year.
  • Intangibles hit $7.8 million in Q4 2025 for Vir Biotechnology, down from $7.9 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $33.7 million in Q1 2021 to a low of $7.8 million in Q4 2025.
  • Historically, Intangibles has averaged $23.6 million across 5 years, with a median of $25.5 million in 2023.
  • Biggest five-year swings in Intangibles: soared 596.27% in 2021 and later tumbled 64.07% in 2025.
  • Year by year, Intangibles stood at $33.3 million in 2021, then fell by 1.6% to $32.8 million in 2022, then tumbled by 31.11% to $22.6 million in 2023, then plummeted by 64.02% to $8.1 million in 2024, then dropped by 3.33% to $7.8 million in 2025.
  • Business Quant data shows Intangibles for VIR at $7.8 million in Q4 2025, $7.9 million in Q3 2025, and $8.0 million in Q2 2025.